Kidney Disease

Among older adults participating in the Systolic Blood Pressure Intervention Trial, a low eGFR without albuminuria was associated with a higher mortality rate but not with increased risk of cardiovascular events, results showed.

Members of the U.S. Senate have reintroduced a bill that would provide Medicare funding for preventive screenings for kidney disease, add payments for innovative devices and allow patients younger than 65 years to buy Medigap coverage.

Multidisciplinary experts from across cardiometabolic subspecialties will gather again to showcase the latest clinical research at the Heart in Diabetes CME Conference.

In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that 6% of patients treated for heart failure progressed to dialysis within 1 year after hospitalization.

Patients with chronic kidney disease who received medication to treat their depression did not see a reduction in adverse health risks for hospitalizations and mortality, a recently published study shows.

Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.

LONG BEACH, Calif. — Getting educated on the pros and cons of Medicare Advantage may be “critically important” for patients and providers in nephrology, a speaker said, here.

LONG BEACH, Calif. — Gaurav Jain, MD, of the University of Alabama at Birmingham discussed value-based care in nephrology at the National Kidney Foundation Spring Clinical Meetings, here.

LONG BEACH, Calif. — Off-unit sessions organized around games, resources, fresh food and meal preparation improved patient knowledge around nutrition and kidney disease, resulting in improved phosphorous levels.

The National Kidney Foundation has awarded Lisa Koester, ANP, CS, CNN-NP, MSN, the Carol Mattix Award at the NKF Spring Clinical Meetings in Long Beach, California.